These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 31213529

  • 21. Effects of hydrogen sulfide on mitochondrial function and cellular bioenergetics.
    Paul BD, Snyder SH, Kashfi K.
    Redox Biol; 2021 Jan; 38():101772. PubMed ID: 33137711
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Role of human sulfide: quinone oxidoreductase in H2S metabolism.
    Jackson MR, Melideo SL, Jorns MS.
    Methods Enzymol; 2015 Jan; 554():255-70. PubMed ID: 25725526
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Hydrogen Sulfide, an Endogenous Stimulator of Mitochondrial Function in Cancer Cells.
    Szabo C.
    Cells; 2021 Jan 22; 10(2):. PubMed ID: 33499368
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro.
    Gerő D, Torregrossa R, Perry A, Waters A, Le-Trionnaire S, Whatmore JL, Wood M, Whiteman M.
    Pharmacol Res; 2016 Nov 22; 113(Pt A):186-198. PubMed ID: 27565382
    [Abstract] [Full Text] [Related]

  • 33. Modulation of Catalytic Promiscuity during Hydrogen Sulfide Oxidation.
    Landry AP, Ballou DP, Banerjee R.
    ACS Chem Biol; 2018 Jun 15; 13(6):1651-1658. PubMed ID: 29715001
    [Abstract] [Full Text] [Related]

  • 34. Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.
    Druzhyna N, Szczesny B, Olah G, Módis K, Asimakopoulou A, Pavlidou A, Szoleczky P, Gerö D, Yanagi K, Törö G, López-García I, Myrianthopoulos V, Mikros E, Zatarain JR, Chao C, Papapetropoulos A, Hellmich MR, Szabo C.
    Pharmacol Res; 2016 Nov 15; 113(Pt A):18-37. PubMed ID: 27521834
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cytochrome c Reduction by H2S Potentiates Sulfide Signaling.
    Vitvitsky V, Miljkovic JL, Bostelaar T, Adhikari B, Yadav PK, Steiger AK, Torregrossa R, Pluth MD, Whiteman M, Banerjee R, Filipovic MR.
    ACS Chem Biol; 2018 Aug 17; 13(8):2300-2307. PubMed ID: 29966080
    [Abstract] [Full Text] [Related]

  • 38. Cysteine-derived hydrogen sulfide and gut health: a matter of endogenous or bacterial origin.
    Blachier F, Beaumont M, Kim E.
    Curr Opin Clin Nutr Metab Care; 2019 Jan 17; 22(1):68-75. PubMed ID: 30461448
    [Abstract] [Full Text] [Related]

  • 39. Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation.
    Oláh G, Módis K, Törö G, Hellmich MR, Szczesny B, Szabo C.
    Biochem Pharmacol; 2018 Mar 17; 149():186-204. PubMed ID: 29074106
    [Abstract] [Full Text] [Related]

  • 40. Overproduction of H2S, generated by CBS, inhibits mitochondrial Complex IV and suppresses oxidative phosphorylation in Down syndrome.
    Panagaki T, Randi EB, Augsburger F, Szabo C.
    Proc Natl Acad Sci U S A; 2019 Sep 17; 116(38):18769-18771. PubMed ID: 31481613
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.